These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

541 related articles for article (PubMed ID: 29672864)

  • 81. Pharmacologic Inhibition of the Menin-MLL Interaction Leads to Transcriptional Repression of
    Kempinska K; Malik B; Borkin D; Klossowski S; Shukla S; Miao H; Wang J; Cierpicki T; Grembecka J
    Mol Cancer Ther; 2018 Jan; 17(1):26-38. PubMed ID: 29142068
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Synthetic siRNA targeting the breakpoint of EWS/Fli-1 inhibits growth of Ewing sarcoma xenografts in a mouse model.
    Takigami I; Ohno T; Kitade Y; Hara A; Nagano A; Kawai G; Saitou M; Matsuhashi A; Yamada K; Shimizu K
    Int J Cancer; 2011 Jan; 128(1):216-26. PubMed ID: 20648560
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Variable expression of PIK3R3 and PTEN in Ewing Sarcoma impacts oncogenic phenotypes.
    Niemeyer BF; Parrish JK; Spoelstra NS; Joyal T; Richer JK; Jedlicka P
    PLoS One; 2015; 10(1):e0116895. PubMed ID: 25603314
    [TBL] [Abstract][Full Text] [Related]  

  • 84. IGF-1R/MDM2 relationship confers enhanced sensitivity to RITA in Ewing sarcoma cells.
    Di Conza G; Buttarelli M; Monti O; Pellegrino M; Mancini F; Pontecorvi A; Scotlandi K; Moretti F
    Mol Cancer Ther; 2012 Jun; 11(6):1247-56. PubMed ID: 22461661
    [TBL] [Abstract][Full Text] [Related]  

  • 85. The PAF complex regulation of Prmt5 facilitates the progression and maintenance of MLL fusion leukemia.
    Serio J; Ropa J; Chen W; Mysliwski M; Saha N; Chen L; Wang J; Miao H; Cierpicki T; Grembecka J; Muntean AG
    Oncogene; 2018 Jan; 37(4):450-460. PubMed ID: 28945229
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Menin epigenetically represses Hedgehog signaling in MEN1 tumor syndrome.
    Gurung B; Feng Z; Iwamoto DV; Thiel A; Jin G; Fan CM; Ng JM; Curran T; Hua X
    Cancer Res; 2013 Apr; 73(8):2650-8. PubMed ID: 23580576
    [TBL] [Abstract][Full Text] [Related]  

  • 87. BMI-1 promotes ewing sarcoma tumorigenicity independent of CDKN2A repression.
    Douglas D; Hsu JH; Hung L; Cooper A; Abdueva D; van Doorninck J; Peng G; Shimada H; Triche TJ; Lawlor ER
    Cancer Res; 2008 Aug; 68(16):6507-15. PubMed ID: 18701473
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Molecular basis of the mixed lineage leukemia-menin interaction: implications for targeting mixed lineage leukemias.
    Grembecka J; Belcher AM; Hartley T; Cierpicki T
    J Biol Chem; 2010 Dec; 285(52):40690-8. PubMed ID: 20961854
    [TBL] [Abstract][Full Text] [Related]  

  • 89. An Oral Formulation of YK-4-279: Preclinical Efficacy and Acquired Resistance Patterns in Ewing Sarcoma.
    Lamhamedi-Cherradi SE; Menegaz BA; Ramamoorthy V; Aiyer RA; Maywald RL; Buford AS; Doolittle DK; Culotta KS; O'Dorisio JE; Ludwig JA
    Mol Cancer Ther; 2015 Jul; 14(7):1591-604. PubMed ID: 25964201
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Small molecule inhibition of Ewing sarcoma cell growth via targeting the long non coding RNA HULC.
    Mercatelli N; Fortini D; Palombo R; Paronetto MP
    Cancer Lett; 2020 Jan; 469():111-123. PubMed ID: 31639426
    [TBL] [Abstract][Full Text] [Related]  

  • 91. ABT-869 inhibits the proliferation of Ewing Sarcoma cells and suppresses platelet-derived growth factor receptor beta and c-KIT signaling pathways.
    Ikeda AK; Judelson DR; Federman N; Glaser KB; Landaw EM; Denny CT; Sakamoto KM
    Mol Cancer Ther; 2010 Mar; 9(3):653-60. PubMed ID: 20197394
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Targeting Serine in Cancer: Is Two Better Than One?
    Buqué A; Galluzzi L; Montrose DC
    Trends Cancer; 2021 Aug; 7(8):668-670. PubMed ID: 34219053
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Trithorax complex component Menin controls differentiation and maintenance of T helper 17 cells.
    Watanabe Y; Onodera A; Kanai U; Ichikawa T; Obata-Ninomiya K; Wada T; Kiuchi M; Iwamura C; Tumes DJ; Shinoda K; Yagi R; Motohashi S; Hirahara K; Nakayama T
    Proc Natl Acad Sci U S A; 2014 Sep; 111(35):12829-34. PubMed ID: 25136117
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Suppression of deacetylase SIRT1 mediates tumor-suppressive NOTCH response and offers a novel treatment option in metastatic Ewing sarcoma.
    Ban J; Aryee DN; Fourtouna A; van der Ent W; Kauer M; Niedan S; Machado I; Rodriguez-Galindo C; Tirado OM; Schwentner R; Picci P; Flanagan AM; Berg V; Strauss SJ; Scotlandi K; Lawlor ER; Snaar-Jagalska E; Llombart-Bosch A; Kovar H
    Cancer Res; 2014 Nov; 74(22):6578-88. PubMed ID: 25281719
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Therapeutic Targeting of KDM1A/LSD1 in Ewing Sarcoma with SP-2509 Engages the Endoplasmic Reticulum Stress Response.
    Pishas KI; Drenberg CD; Taslim C; Theisen ER; Johnson KM; Saund RS; Pop IL; Crompton BD; Lawlor ER; Tirode F; Mora J; Delattre O; Beckerle MC; Callen DF; Sharma S; Lessnick SL
    Mol Cancer Ther; 2018 Sep; 17(9):1902-1916. PubMed ID: 29997151
    [TBL] [Abstract][Full Text] [Related]  

  • 96. ZEB1 Transcriptionally Activates PHGDH to Facilitate Carcinogenesis and Progression of HCC.
    Wang H; Lin F; Xu Z; Yu S; Li G; Liao S; Zhao W; Zhang F; Wang J; Wang S; Ouyang C; Zhang C; Xia H; Wu Y; Jiang B; Li Q
    Cell Mol Gastroenterol Hepatol; 2023; 16(4):541-556. PubMed ID: 37331567
    [TBL] [Abstract][Full Text] [Related]  

  • 97. MLL1 inhibition reduces IgM levels in Waldenström macroglobulinemia.
    Karbalivand M; Almada LL; Ansell SM; Fernandez-Zapico ME; Elsawa SF
    Leuk Res; 2022 May; 116():106841. PubMed ID: 35462170
    [TBL] [Abstract][Full Text] [Related]  

  • 98. p53 Protein-mediated regulation of phosphoglycerate dehydrogenase (PHGDH) is crucial for the apoptotic response upon serine starvation.
    Ou Y; Wang SJ; Jiang L; Zheng B; Gu W
    J Biol Chem; 2015 Jan; 290(1):457-66. PubMed ID: 25404730
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Structure-Based Discovery of M-89 as a Highly Potent Inhibitor of the Menin-Mixed Lineage Leukemia (Menin-MLL) Protein-Protein Interaction.
    Aguilar A; Zheng K; Xu T; Xu S; Huang L; Fernandez-Salas E; Liu L; Bernard D; Harvey KP; Foster C; McEachern D; Stuckey J; Chinnaswamy K; Delproposto J; Kampf JW; Wang S
    J Med Chem; 2019 Jul; 62(13):6015-6034. PubMed ID: 31244110
    [TBL] [Abstract][Full Text] [Related]  

  • 100. High-throughput Chemical Screening Identifies Focal Adhesion Kinase and Aurora Kinase B Inhibition as a Synergistic Treatment Combination in Ewing Sarcoma.
    Wang S; Hwang EE; Guha R; O'Neill AF; Melong N; Veinotte CJ; Conway Saur A; Wuerthele K; Shen M; McKnight C; Alexe G; Lemieux ME; Wang A; Hughes E; Xu X; Boxer MB; Hall MD; Kung A; Berman JN; Davis MI; Stegmaier K; Crompton BD
    Clin Cancer Res; 2019 Jul; 25(14):4552-4566. PubMed ID: 30979745
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 28.